Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future
In the past 20 years, patients with rheumatoid arthritis (RA), Crohn's disease (CD), and other immune diseases have witnessed the impact of a great treatment advance with the availability of biological TNFα inhibitors. With 5 approved anti-TNFα biologics on the market and soon available biosimi...
Main Authors: | Hongtao Zhang, Nelson Shi, Zhuo Diao, Youhai Chen, Yejia Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2021-01-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304220300349 |
Similar Items
-
Targeting the TNF-α–TNFR interaction with EGCG to block NF-κB signaling in human synovial fibroblasts
by: Huanhuan Xu, et al.
Published: (2023-05-01) -
Complexity of TNF-α Signaling in Heart Disease
by: Filip Rolski, et al.
Published: (2020-10-01) -
Leveraging the tolerogenic potential of TNF-α and regulatory B cells in organ transplantation
by: Sonya A. Poznansky, et al.
Published: (2023-04-01) -
Anti-TNF-α Compounds as a Treatment for Depression
by: Sarit Uzzan, et al.
Published: (2021-04-01) -
Potential regulatory mechanism of TNF-α/TNFR1/ANXA1 in glioma cells and its role in glioma cell proliferation
by: Zhu Xiaotian, et al.
Published: (2022-03-01)